Understanding the uptake of new hip replacement implants in the UK: a cohort study using data from the National Joint Registry for England and Wales

Abstract

ObjectivesPrimary: describe uptake of new implant components (femoral stem or acetabular cup/shell) for total hip replacements (THRs) in the National Joint Registry for England and Wales (NJR). Secondary: compare the characteristics of: (a) surgeons and (b) patients who used/received new rather than established components.DesignCohort of 618 393 primary THRs performed for osteoarthritis (±other indications) by 4979 surgeons between 2008 and 2017 in England and Wales from the NJR. We described the uptake of new (first recorded use >2008, used within 5 years) stems/cups, and variation in uptake by surgeons (primary objectives). We explored surgeon-level and patient-level factors associated with use/receipt of new components with logistic regression models (secondary objectives).OutcomesPrimary outcomes: total number of new cups/stems, proportion of operations using new versus established components. Secondary outcomes: odds of: (a) a surgeon using a new cup/stem in a calendar-year, (b) a patient receiving a new rather than established cup/stem.ResultsSixty-eight new cups and 72 new stems were used in 47 606 primary THRs (7.7%) by 2005 surgeons (40.3%) 2008–2017. Surgeons used a median of one new stem and cup (25%–75%=1–2 both, max=10 cups, max=8 stems). Surgeons performed a median total of 22 THRs (25%–75%=5–124, range=1–3938) in the period 2008–2017. Surgeons used new stems in a median of 5.0% (25%–75%=1.3%–16.1%) and new cups in a median of 9.4% (25%–75%=2.8%–26.7%) of their THRs. Patients aged <55 years old versus those 55–80 had higher odds of receiving a new rather than established stem (OR=1.83, 95% CI=1.73–1.93) and cup (OR=1.31, 95% CI=1.25–1.37). Women had lower odds of receiving a new stem (OR=0.87, 95% CI=0.84–0.90), higher odds of receiving a new cup (OR=1.06, 95% CI=1.03–1.09).ConclusionsLarge numbers of new THR components have been introduced in the NJR since 2008. 40% of surgeons have tried new components, with wide variation in how many types and frequency they have been used.